PL387319A1 - Nowy szczep bakterii Salmonella enterica s. Typhimurium, jego zastosowanie i sposób otrzymywania terapeutycznego wektora szczepionkowego - Google Patents

Nowy szczep bakterii Salmonella enterica s. Typhimurium, jego zastosowanie i sposób otrzymywania terapeutycznego wektora szczepionkowego

Info

Publication number
PL387319A1
PL387319A1 PL387319A PL38731909A PL387319A1 PL 387319 A1 PL387319 A1 PL 387319A1 PL 387319 A PL387319 A PL 387319A PL 38731909 A PL38731909 A PL 38731909A PL 387319 A1 PL387319 A1 PL 387319A1
Authority
PL
Poland
Prior art keywords
obtaining
application
salmonella enterica
new strain
vaccine vector
Prior art date
Application number
PL387319A
Other languages
English (en)
Other versions
PL213066B1 (pl
Inventor
Michał Bereta
Original Assignee
Uniwersytet Jagielloński W Krakowie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński W Krakowie filed Critical Uniwersytet Jagielloński W Krakowie
Priority to PL387319A priority Critical patent/PL213066B1/pl
Priority to PCT/PL2010/050005 priority patent/WO2010095966A1/en
Priority to ES10713040T priority patent/ES2430861T3/es
Priority to EP10713040.3A priority patent/EP2406277B1/en
Priority to US13/148,139 priority patent/US8916372B2/en
Publication of PL387319A1 publication Critical patent/PL387319A1/pl
Publication of PL213066B1 publication Critical patent/PL213066B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Oncology (AREA)
PL387319A 2009-02-23 2009-02-23 Nowy szczep bakterii Salmonella enterica s. Typhimurium, jego zastosowanie i sposób otrzymywania terapeutycznego wektora szczepionkowego PL213066B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL387319A PL213066B1 (pl) 2009-02-23 2009-02-23 Nowy szczep bakterii Salmonella enterica s. Typhimurium, jego zastosowanie i sposób otrzymywania terapeutycznego wektora szczepionkowego
PCT/PL2010/050005 WO2010095966A1 (en) 2009-02-23 2010-02-23 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector
ES10713040T ES2430861T3 (es) 2009-02-23 2010-02-23 Nueva cepa de Salmonella enterica s. Typhimurium, su uso y un procedimiento para obtener un vector de vacuna terapéutico
EP10713040.3A EP2406277B1 (en) 2009-02-23 2010-02-23 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector
US13/148,139 US8916372B2 (en) 2009-02-23 2010-02-23 Strain of Salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL387319A PL213066B1 (pl) 2009-02-23 2009-02-23 Nowy szczep bakterii Salmonella enterica s. Typhimurium, jego zastosowanie i sposób otrzymywania terapeutycznego wektora szczepionkowego

Publications (2)

Publication Number Publication Date
PL387319A1 true PL387319A1 (pl) 2010-08-30
PL213066B1 PL213066B1 (pl) 2013-01-31

Family

ID=42236362

Family Applications (1)

Application Number Title Priority Date Filing Date
PL387319A PL213066B1 (pl) 2009-02-23 2009-02-23 Nowy szczep bakterii Salmonella enterica s. Typhimurium, jego zastosowanie i sposób otrzymywania terapeutycznego wektora szczepionkowego

Country Status (5)

Country Link
US (1) US8916372B2 (pl)
EP (1) EP2406277B1 (pl)
ES (1) ES2430861T3 (pl)
PL (1) PL213066B1 (pl)
WO (1) WO2010095966A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
CN102477440A (zh) * 2010-11-29 2012-05-30 南京大学 治疗基因在厌氧组织靶向递送和选择性稳定表达方法及应用
US10987432B2 (en) * 2013-09-05 2021-04-27 The University Of Hong Kong Therapeutic delivery and expression system, methods and uses thereof
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US20240009252A1 (en) * 2020-08-18 2024-01-11 Curators Of The University Of Missouri Compositions and methods of treatment comprising tumor-targeting bacteria and chemotherapy or immunotherapy agent
CN114480462A (zh) * 2020-10-26 2022-05-13 南京吉芮康生物科技研究院有限公司 一种减毒沙门氏菌分泌表达ntd结构域蛋白的新型冠状病毒疫苗抗原递呈系统及其应用

Also Published As

Publication number Publication date
ES2430861T3 (es) 2013-11-22
WO2010095966A1 (en) 2010-08-26
US20120164687A1 (en) 2012-06-28
EP2406277A1 (en) 2012-01-18
EP2406277B1 (en) 2013-06-26
PL213066B1 (pl) 2013-01-31
US8916372B2 (en) 2014-12-23

Similar Documents

Publication Publication Date Title
PL387319A1 (pl) Nowy szczep bakterii Salmonella enterica s. Typhimurium, jego zastosowanie i sposób otrzymywania terapeutycznego wektora szczepionkowego
HUE054964T2 (hu) Pirazol-heteroaril készítmény, az elõállítás módja és gyógyászati felhasználása
HK1202270A1 (en) Three-dimesional, prevascularized, engineered tissue constructs, methods of making and methods of using the tissue constructs
EP2279276A4 (en) STAINLESS STEEL PRODUCT, PRODUCT USE AND MANUFACTURING METHOD
HK1174030A1 (en) Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
EP2585804A4 (en) INDEPENDENT TEMPERATURE PRESSURE SENSOR AND ITS RELATED METHODS
SG10201808050YA (en) BIOTECHNOLOGICAL PRODUCTION OF LNT, LNnT AND THE FUCOSYLATED DERIVATIVES THEREOF
PL2468319T3 (pl) Nowy nanoprodukt przydatny w zabiegach profilaktycznych, diagnostycznych oraz leczniczych w medycynie ludzkiej i w weterynarii
HK1209780A1 (en) Non-pathogenic f18 e. coli strain and use thereof f18
PL3260865T3 (pl) Sposób obróbki krwi, produktów krwiopochodnych i narządów
PT2747578T (pt) O método para obter uma estirpe de bacteriófago, estirpes específicas de bacteriófago e sua utilização
HK1207420A1 (en) Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia
EP2546226A4 (en) 1-METHOXYL-2,6,10-TRIMETHYL-1,3,5,9-UNDEC-TETRAENE, PREPARATION METHOD THEREOF AND USES THEREOF
EP2626430A4 (en) YEAST AND YEAST EXTRACT CONTAINING -Glu-ABU, AND PROCESS FOR PRODUCING THE YEAST OR YEAST EXTRACT CONTAINING -Glu-ABU
GB2546243B (en) Biomass, thermal pressure hydrolysis and anaerobic digestion
GB201415841D0 (en) Apparatuses, methods, and systems for the identification and treatment of pulmonary tissue
EP2842940A4 (en) SULFORAPHANE DERIVED COMPOUNDS, METHOD FOR OBTAINING SAME, AND MEDICAL, FOOD, AND COSMETIC USE THEREOF
EP2568805A4 (en) MEDICAL FLUID, METHOD OF TREATMENT AND USE OF THE FLUID
GB2488494B (en) Solution, use and method of preparation thereof
EP2595549B8 (en) Double umbilical identification device mother-infant, and method thereof
EP2435403A4 (en) THIOCOLCHICINE DERIVATIVES AND MANUFACTURING AND USE METHOD THEREFOR
LT2914754T (lt) Lactobacillus delbrueckii bakterijų nauja padermė ir jos panaudojimas bičių duonelės gamybai
ZA201304035B (en) Diarylpyridazinone derivatives,preparation thereof,and use thereof for the treatment of humans
HRP20130379T1 (en) Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
UA66666U (ru) Способ дермабразии поверхностных ожогов в ранние сроки получения травмы с помощью ультразвуковой кавитации